TRIUMF’s Isotope program (1980 to 2017): From imaging to therapy

Synopsis

Over the last three and a half decades TRIUMF has been engaged in cutting edge research making use of a variety of radioisotopes. Initially for use in fundamental studies in Parkinson’s disease using PET. More recently we have begun exploring the production of alpha emitting isotopes for use in cancer therapy.

This talk will provide key examples of what has been accomplished as well as outlining some future prospects.